Literature DB >> 7683561

Ion channel blockade by oximes and recovery of diaphragm muscle from soman poisoning in vitro.

J E Tattersall1.   

Abstract

1. The actions of oximes and related compounds on the nicotinic acetylcholine receptor ion channel at the adult mouse muscle endplate were investigated by use of single-channel recording techniques. The aim of the study was to determine whether the channel-blocking properties of the compounds could contribute to their therapeutic effectiveness against soman poisoning in vitro. 2. Therapeutic effectiveness was assessed in guinea-pig phrenic nerve-hemidiaphragm preparations by measuring the degree of recovery of neuromuscular function produced by the compounds following poisoning by soman. A number of the compounds, including some which lacked the oxime group, produced a significant recovery of neuromuscular function which was unrelated to acetylcholinesterase (AChE) reactivation; this was reversed by washing off the compound, and was therefore attributed to a direct pharmacological action on the muscle. 3. Single channel recordings showed that some of the compounds blocked open nicotinic receptor ion channels in preparations of mouse muscle fibres. The compounds which showed the greatest direct pharmacological actions in diaphragms produce a very fast, flickering blockade of the channels. Several quantitative measures of channel-blocking activity correlated very well with the direct pharmacological action. Furthermore, for two compounds studied in greater detail, the direct action and channel-blocking showed similar concentration-response relationships. 4. The results of this study indicate that the direct pharmacological action of oximes and their analogues against neuromuscular blockade by soman in vitro is due to their channel-blocking activity. The direct action does not correlate well with protection against soman poisoning in vivo, however, which suggests that additional non-reactivating properties of these compounds, at sites other than the neuromuscular junction, may also be important for their therapeutic effectiveness.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7683561      PMCID: PMC1908129          DOI: 10.1111/j.1476-5381.1993.tb13498.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  26 in total

1.  Antidotal action of the oxime HS6 at the soman poisoned neuromuscular junction of the rat and guinea-pig.

Authors:  A P Smith; A W Muir
Journal:  J Pharm Pharmacol       Date:  1977-12       Impact factor: 3.765

2.  Kinetic analysis of end plate currents altered by atropine and scopolamine.

Authors:  M Adler; E X Albuquerque; F J Lebeda
Journal:  Mol Pharmacol       Date:  1978-05       Impact factor: 4.436

3.  Quantitative structure-activity relationships and possible mechanisms of action of bispyridinium oximes as antidotes against pinacolyl methylphosphonofluoridate.

Authors:  C T Su; C P Tang; C Ma; Y S Shih; C Y Liu; M T Wu
Journal:  Fundam Appl Toxicol       Date:  1983 Jul-Aug

4.  The charge carried by single-channel currents of rat cultured muscle cells in the presence of local anaesthetics.

Authors:  E Neher
Journal:  J Physiol       Date:  1983-06       Impact factor: 5.182

5.  Pharmacokinetics of pralidoxime chloride in the rat.

Authors:  M D Green; B G Talbot; C R Clark
Journal:  Life Sci       Date:  1986-12-08       Impact factor: 5.037

6.  The reversal by oximes and their de oximinomethyl analogues of neuromuscular block produced by soman.

Authors:  M C French; J R Wetherell; P D White
Journal:  Eur J Pharmacol       Date:  1983-08-05       Impact factor: 4.432

7.  The efficacy of bispyridinium derivatives in the treatment of organophosphonate poisoning in the guinea-pig.

Authors:  R H Inns; L Leadbeater
Journal:  J Pharm Pharmacol       Date:  1983-07       Impact factor: 3.765

8.  The efficacy of some bis-pyridinium oximes as antidotes to soman in isolated muscles of several species including man.

Authors:  O Wolthuis; R A Vanwersch; H J Van der Wiel
Journal:  Eur J Pharmacol       Date:  1981-03-26       Impact factor: 4.432

9.  Analysis of oxime-induced neuromuscular recovery in guinea pig, rat and man following soman poisoning in vitro.

Authors:  A P Smith; H J Van der Wiel; O L Wolthuis
Journal:  Eur J Pharmacol       Date:  1981-03-26       Impact factor: 4.432

10.  Toxicology and pharmacology of bispyridium oximes--insight into the mechanism of action vs Soman poisoning in vivo.

Authors:  J G Clement
Journal:  Fundam Appl Toxicol       Date:  1981 Mar-Apr
View more
  15 in total

1.  Synthesis and Molecular Properties of Nerve Agent Reactivator HLö-7 Dimethanesulfonate.

Authors:  Fu-Lian Hsu; Su Y Bae; Jack McGuire; Dana R Anderson; Stephanie M Bester; Jude J Height; Scott D Pegan; Andrew J Walz
Journal:  ACS Med Chem Lett       Date:  2019-03-28       Impact factor: 4.345

2.  In vitro oxime-induced reactivation of various molecular forms of soman-inhibited acetylcholinesterase in striated muscle from rat, monkey and human.

Authors:  J G Clement; N Erhardt
Journal:  Arch Toxicol       Date:  1994       Impact factor: 5.153

3.  Effects of 2,3-butanedione monoxime (BDM) on calcium channels expressed in Xenopus oocytes.

Authors:  T J Allen; G Mikala; X Wu; A C Dolphin
Journal:  J Physiol       Date:  1998-04-01       Impact factor: 5.182

4.  Bisquaternary pyridinium oximes: Comparison of in vitro reactivation potency of compounds bearing aliphatic linkers and heteroaromatic linkers for paraoxon-inhibited electric eel and recombinant human acetylcholinesterase.

Authors:  Sandip B Bharate; Lilu Guo; Tony E Reeves; Douglas M Cerasoli; Charles M Thompson
Journal:  Bioorg Med Chem       Date:  2009-11-27       Impact factor: 3.641

5.  Acute toxicity of several organophosphorous insecticides and protection by cholinergic antagonists and 2-PAM on Artemia salina larvae.

Authors:  S Sánchez-Fortún; F Sanz; M V Barahona
Journal:  Arch Environ Contam Toxicol       Date:  1996-10       Impact factor: 2.804

6.  Non-reactivating effects of HI-6 on hippocampal neurotransmission.

Authors:  B P Melchers; A L van der Laaken; R W Busker; P L Bruijnzeel; H P Van Helden
Journal:  Arch Toxicol       Date:  1994       Impact factor: 5.153

7.  Reactivation of sarin-inhibited pig brain acetylcholinesterase using oxime antidotes.

Authors:  Kamil Kuca; Daniel Jun
Journal:  J Med Toxicol       Date:  2006-12

8.  Cardiorespiratory function in nerve agent poisoned and oxime + atropine treated guinea-pigs: effect of pyridostigmine pretreatment.

Authors:  F Worek; L Szinicz
Journal:  Arch Toxicol       Date:  1995       Impact factor: 5.153

9.  Comparison of the therapeutic effects and pharmacokinetics of HI-6, HLö-7, HGG-12, HGG-42 and obidoxime following non-reactivatable acetylcholinesterase inhibition in rats.

Authors:  H P van Helden; H J van der Wiel; J J Zijlstra; B P Melchers; R W Busker
Journal:  Arch Toxicol       Date:  1994       Impact factor: 5.153

Review 10.  Nicotinic antagonists in the treatment of nerve agent intoxication.

Authors:  Robert D Sheridan; Andrew P Smith; Simon R Turner; John E H Tattersall
Journal:  J R Soc Med       Date:  2005-03       Impact factor: 18.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.